Skip to main content

Find Clinical Trials

Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients

NCT00481390

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: GSK Investigational Site Helsinki, Finland

GSK Investigational Site Dublin, Ireland

GSK Investigational Site Alkmaar, Netherlands

GSK Investigational Site Amsterdam, Netherlands

View all 20 locations

View Trial Details

Completed

Development of a New HIV Vaccine

NCT00051922

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

NCT00192634

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Holdsworth House General Practice - Byron Bay Byron Bay, New South Wales, Australia

Lismore Sexual Health Clinic - Northen Rivers Area Health Service Lismore, New South Wales, Australia

John Hunter Hospital Newcastle, New South Wales, Australia

407 Doctors Sydney, New South Wales, Australia

View all 31 locations

View Trial Details

Completed

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

NCT00373048

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Tropical Disease Research Center Ndola, Cupperbelt, Zambia

View Trial Details

Completed

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

NCT00315432

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

NCT00111280

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

NCT01190124

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

NCT00225303

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

NCT00964327

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details